Larimar Therapeutics, Inc.
LRMR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$81 | -$37 | -$35 | -$51 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $9 | $0 | $7 | $5 |
| Change in WC | $6 | -$3 | $2 | $3 |
| Other Non-Cash | -$5 | $6 | -$1 | -$0 |
| Operating Cash Flow | -$71 | -$33 | -$28 | -$42 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | -$0 |
| Inv. Purchases | -$228 | -$101 | -$134 | -$8 |
| Inv. Sales/Matur. | $143 | $135 | $43 | $33 |
| Other Inv. Act. | $0 | $0 | -$0 | $0 |
| Investing Cash Flow | -$85 | $33 | -$91 | $24 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $162 | $0 | $75 | $20 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $162 | $0 | $75 | $20 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $6 | -$0 | -$43 | $2 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $28 | $27 | $71 | $69 |
| End Cash | $34 | $27 | $28 | $71 |
| Free Cash Flow | -$71 | -$34 | -$28 | -$42 |